A detailed history of Keystone Financial Group transactions in Pfizer Inc stock. As of the latest transaction made, Keystone Financial Group holds 70,144 shares of PFE stock, worth $1.85 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
70,144
Previous 60,572 15.8%
Holding current value
$1.85 Million
Previous $1.69 Million 19.78%
% of portfolio
0.69%
Previous 0.62%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $265,144 - $300,465
9,572 Added 15.8%
70,144 $2.03 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $213,396 - $250,060
8,448 Added 16.21%
60,572 $1.69 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $368,026 - $422,611
14,215 Added 37.5%
52,124 $1.45 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $92,474 - $120,113
3,539 Added 10.3%
37,909 $1.09 Million
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $68,576 - $80,158
2,137 Added 6.63%
34,370 $1.14 Million
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $146,286 - $169,249
4,050 Added 14.37%
32,233 $1.18 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $4,634 - $6,049
-111 Reduced 0.39%
28,183 $1.44 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $45,510 - $55,556
1,040 Added 3.82%
28,294 $1.24 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $791 - $937
-17 Reduced 0.06%
27,254 $1.43 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $76,539 - $94,842
1,673 Added 6.54%
27,271 $1.41 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $164,288 - $243,530
3,976 Added 18.39%
25,598 $1.51 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $15,307 - $19,663
390 Added 1.84%
21,622 $930,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $7,253 - $8,217
202 Added 0.96%
21,232 $831,000
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $44,541 - $50,234
1,330 Added 6.75%
21,030 $762,000
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $36,147 - $45,964
1,080 Added 5.8%
19,700 $725,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $33,337 - $39,112
1,050 Added 5.98%
18,620 $683,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $3,042 - $3,690
101 Added 0.58%
17,570 $575,000
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $55,114 - $78,746
2,039 Added 13.21%
17,469 $570,000
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $12,641 - $14,346
384 Added 2.55%
15,430 $605,000
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $15,790 - $20,475
-486 Reduced 3.13%
15,046 $541,000
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $10,280 - $11,542
278 Added 1.82%
15,532 $673,000
Q1 2019

May 07, 2019

BUY
$37.5 - $41.2 $30,075 - $33,042
802 Added 5.55%
15,254 $648,000
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $12,502 - $14,254
-325 Reduced 2.2%
14,452 $631,000
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $141,775 - $171,964
4,113 Added 38.57%
14,777 $654,000
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $9,498 - $10,126
-288 Reduced 2.63%
10,664 $387,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $14,997 - $17,399
470 Added 4.48%
10,952 $384,000
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $348,631 - $369,909
10,482
10,482 $382,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Keystone Financial Group Portfolio

Follow Keystone Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.